Ontology highlight
ABSTRACT:
SUBMITTER: Yang L
PROVIDER: S-EPMC9675340 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
Yang Liyan L Yang Dengfeng D Wang Qingyan Q Li Juan J Li Hong-Liang HL Pan Lixia L
PeerJ 20221116
The antitumor drug doxorubicin is widely used in clinical practice. However, the low yield and high cost of this drug highlight the urgent need for cost-effective processes to rapidly manufacture antitumor drugs at scale. In the biosynthesis pathway, the multi-functional cytochrome P450 enzyme DoxA catalyzes the last three steps of hydroxylation. The final conversion of daunorubicin to doxorubicin is the rate-limiting step. In our work, the DoxA has been expressed with the ferredoxin reductase F ...[more]